Interaction of simian virus 40 small-T antigen produced in bacteria with 56K and 32K proteins of animal cells.

Por Bossert, A, Mulgaonkar, P, Rundell, K
Publicado em 1985

The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression

Por Traish, Abdulmaged M., Mulgaonkar, Ashwini, Giordano, Nicholas
Publicado em 2014

ELIXIR-A: An Interactive Visualization Tool for Multi-Target Pharmacophore Refinement

Por Haoqi Wang, Nirmitee Mulgaonkar, Lisa M. Pérez, Sandun Fernando
Publicado em 2022-04-01

Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone Antimicrobials

Por Mulgaonkar, Aditi, Venitz, Jürgen, Gründemann, Dirk, Sweet, Douglas H.
Publicado em 2013

Barriers to Living Donor Kidney Transplantation among Black or Older Transplant Candidates

Por Weng, Francis L., Reese, Peter P., Mulgaonkar, Shamkant, Patel, Anup M.
Publicado em 2010

Organic Anion Transporter 6 (Slc22a20) Specificity and Sertoli Cell-Specific Expression Provide New Insight on Potential Endogenous Roles

Por Schnabolk, Gloriane W., Gupta, Bhawna, Mulgaonkar, Aditi, Kulkarni, Mrugaya, Sweet, Douglas H.
Publicado em 2010

Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial

Por Bunnapradist, S, Ciechanowski, K, West-Thielke, P, Mulgaonkar, S, Rostaing, L, Vasudev, B, Budde, K
Publicado em 2013

Characteristics of compatible pair participants in kidney paired donation at a single center

Por Weng, Francis L., Grogan, Tracy, Patel, Anup M., Mulgaonkar, Shamkant, Morgievich, Marie M.
Publicado no Clin Transplant (2017)

Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis

Por Melancon, Keith, Mulgaonkar, Shamkant P., Delcoro, Carlos, Wiland, Anne, McCague, Kevin, Shihab, Fuad S.
Publicado em 2013

Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus

Por Shihab, F., Qazi, Y., Mulgaonkar, S., McCague, K., Patel, D., Peddi, V. R., Shaffer, D.
Publicado no Am J Transplant (2017)

Health care follow-up by live kidney donors more than 3 years post-nephrectomy

Por Weng, Francis L., Reese, Peter P., Waterman, Amy D., Soto, Angelo G., Demissie, Kitaw, Mulgaonkar, Shamkant
Publicado em 2012

Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors

Por Moeendarbari, Sina, Tekade, Rakesh, Mulgaonkar, Aditi, Christensen, Preston, Ramezani, Saleh, Hassan, Gedaa, Jiang, Ruiqian, Öz, Orhan K., Hao, Yaowu, Sun, Xiankai
Publicado no Sci Rep (2016)

Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with cirolimus or ciclosporin in renal transplant patients

Por Pescovitz, Mark D, Vincenti, Flavio, Hart, Marquis, Melton, Larry, Whelchel, John, Mulgaonkar, Shamkant, McKay, Diane, Leung, Mimi, Calleja, Elizabeth, Bouw, M René
Publicado em 2007

Characteristics and evaluation of geographically distant versus geographically nearby living kidney donors

Por Weng, Francis L., Lee, David C., Dhillon, Navdeep, Tibaldi, Kim N., Davis, LaShara A., Patel, Anup M., Goldberg, Ryan J., Morgievich, Marie, Mulgaonkar, Shamkant
Publicado no Transplant Proc (2016)

PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response

Por Joseph Vento, Aditi Mulgaonkar, Layton Woolford, Kien Nham, Alana Christie, Aditya Bagrodia, Alberto Diaz de Leon, Raquibul Hannan, Isaac Bowman, Renee M. McKay, Payal Kapur, Guiyang Hao, Xiankai Sun, James Brugarolas
Publicado em 2019-06-01

Control of cerebral ischemia with magnetic nanoparticles

Por Jia, Jie-Min, Chowdary, Praveen D, Gao, Xiaofei, Ci, Bo, Li, Wenjun, Mulgaonkar, Aditi, Plautz, Erik J, Hassan, Gedaa, Kumar, Amit, Stowe, Ann M, Yang, Shao-Hua, Zhou, Wei, Sun, Xiankai, Cui, Bianxiao, Ge, Woo-Ping
Publicado no Nat Methods (2016)

PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

Por Tang, Haidong, Liang, Yong, Anders, Robert A., Taube, Janis M., Qiu, Xiangyan, Mulgaonkar, Aditi, Liu, Xin, Harrington, Susan M., Guo, Jingya, Xin, Yangchun, Xiong, Yahong, Nham, Kien, Silvers, William, Hao, Guiyang, Sun, Xiankai, Chen, Mingyi, Hannan, Raquibul, Qiao, Jian, Dong, Haidong, Peng, Hua, Fu, Yang-Xin
Publicado no J Clin Invest (2018)